Horizon Therapeutics Public Ltd Co

RENAISSANCE TECHNOLOGIES LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

3,433,349

Value ($000)

397,204

Weight

0.7%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	397,204	0.7%	3,433,349	9/30/2023
2023 Q2	8/11/2023	354,704	0.5%	3,448,749	6/30/2023
2023 Q1	5/12/2023	367,633	0.5%	3,368,449	3/31/2023
2022 Q4	2/13/2023	190,621	0.3%	1,675,049	12/31/2022
2022 Q3	11/14/2022	96,639	0.1%	1,561,466	9/30/2022
2022 Q2	8/12/2022	138,804	0.2%	1,740,266	6/30/2022
2022 Q1	5/13/2022	213,131	0.3%	2,025,766	3/31/2022
2021 Q4	2/11/2022	245,377	0.3%	2,277,066	12/31/2021
2021 Q3	11/12/2021	356,165	0.5%	3,251,463	9/30/2021
2021 Q2	8/13/2021	396,815	0.5%	4,237,663	6/30/2021
2021 Q1	5/13/2021	479,525	0.6%	5,209,963	3/31/2021
2020 Q4	2/10/2021	497,344	0.5%	6,798,963	12/31/2020
2020 Q3	11/13/2020	682,098	0.7%	8,780,875	9/30/2020
2020 Q2	8/13/2020	573,190	0.5%	10,312,875	6/30/2020
2020 Q1	5/14/2020	314,673	0.3%	10,623,675	3/31/2020
2019 Q4	2/13/2020	365,644	0.3%	10,100,675	12/31/2019